Four Years After Covid-19 Success, mRNA Vaccines Aren’t Ready for Bird Flu
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic ...
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...
News Tribune5 天
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and ...
Why Moderna Stock Jumped Over 20% This Week
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
Where Will Moderna Be in 3 Years?
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...
Moderna: Is Stock a Buy? Breaking Down the Latest Guidance
"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...
Is Moderna Stock a Buy?
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
Yahoo News11 天
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the ... July 2024 to help expedite the development of an mRNA vaccine that could be used for bird flu. mRNA technology is the same type that ...